TAINAN, Taiwan--(BUSINESS WIRE)--ScinoPharm Taiwan, the oncological API specialist, recently announced that the US Food and Drug Administration (FDA) had assigned a drug master file (DMF) number for its anticancer active ingredient Docetaxel. The company believes it is the first US DMF filer for the product.